Paris-Trousseau_thrombocytopenia

Paris-Trousseau syndrome

Paris-Trousseau syndrome

Medical condition

Paris-Trousseau syndrome (PTS) is an inherited disorder characterized by mild hemorrhagic tendency associated with 11q chromosome deletion.[2][3] It manifests as a granular defect within an individual's platelets. It is characterized by thrombocytes with defects in α-granule components which affects the cell's surface area and, consequently, its ability to spread when necessary.[citation needed]

Quick Facts Other names ...

FLI1 has been suggested as a candidate.[4]

See also

References

  1. [1]
    "Paris-Trousseau thrombocytopenia | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 15 March 2019.
  2. [2]
    "OMIM Entry - # 188025 - THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT". omim.org. Retrieved 15 March 2019.
  3. [3]
    Krishnamurti L, Neglia JP, Nagarajan R, et al. (April 2001). "Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome". Am. J. Hematol. 66 (4): 295–9. doi:10.1002/ajh.1061. PMID 11279643. S2CID 20979492.
  4. [4]
    Raslova H, Komura E, Le Couédic JP, et al. (July 2004). "FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia". J. Clin. Invest. 114 (1): 77–84. doi:10.1172/JCI21197. PMC 437972. PMID 15232614.


Stub icon

This genetic disorder article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Paris-Trousseau_thrombocytopenia, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.